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Postoperative Infections after Spinal Procedures
Nikolaos Syrmos, Vasilios Valadakis, Konstantinos Grigoriou,
Evangellia Grisbolaki, Dimitrios Arvanitakis. Neurosurgical
Department, Venizeleio General Hospital, Heraklion, Crete,
Greece
Introduction: The rate of postoperative infections following spinal
procedures varies widely depending most of the times in factors
such as- the nature of the procedure, the patient' s diagnosis, the
preoperative comorbidities and other risk factors. A retrospective
case control analysis of 28 cases of postoperative infection follow-
ing spinal procedures was performed.
Material and Methods: A review of 200 spinal procedures revealed
that a postoperative infection developed in 28 patients (14%).
Preoperative risk factors reviewed included smoking and alcohol
abuse, diabetes, previous spinal surgery, previous infections and
body mass index. Intraoperative factors reviewed included the type
of procedures, the operating time and the use of instrumenta-
tion.
Results: The majority of infections (20 cases-71.4%) occurred dur-
ing the early postoperative period (< 6 months). Factors such as-
age of >65 years, smoking and alcohol abuse, diabetes, previous
surgical infection and increased body mass index were statistically
significant preoperative risk factors. The most common organism
cultured from the wounds was Staphylococcus aureus. All patients
were treated with surgical irrigation and débridement, and appro-
priate antibiotics to treat the cultured organism.
Conclusions: It may be appropriate to increase the duration of
prophylactic antibiotics or implement other measures to decrease
the incidence of infection for high risk patients. Whereas extended
prophylactics should be considered in posterior instrumentation,
especially when risk factors are apparent.
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Fungal Infections in Patients Hospitalized in Intensive
Medical Care Unit
Ewa Swoboda-Kopec1, Ewa Stelmach1, Beata Sulik-Tyszka1,
Irena Netsvyetayeva1, Dariusz Kawecki1, Magdalena Sikora1,
Sylwia Blachnio1, Andrzej Kanski2, Miroslaw Luczak1. 1Dept. of
Medical Microbiology Medical University of Warsaw, Poland;
2Dept. of Anaesthesiology and Intensive Care Medical University
of Warsaw, Poland
Introduction: Fungal infections in patients hospitalized in Intensive
Medical Care Unit are a serious clinical problem. Candida genus is
the leading fungal pathogen in intensive care units.
Objective: In our study we analyzed the occurrence of fungal
strains and their susceptibility to antifungal agents in samples of
clinical material taken from patients hospitalized in Intensive Med-
ical Care Unit of Central Clinical Hospital in Warsaw in 2007.
Material and Methods: In total 1697 samples of clinical materials
from hospitalized patients were tested in Microbiological Labora-
tory. From Intensive Care Unit the most common clinical speci-
mens were taken from respiratory tract 22 (30%), digestive tract
(stool) 15 (21%), urine samples 14 (19%), blood 13 (18%), wound
swabs 5 (7%) and other 4 (5%). Specimens were cultured on Sabo-
raud medium plates supplemented with gentamicine and chloram-
phenicol (Becton Dickinson). Isolated strains were identified using
CHROMagar Candida agar and automatic test ID32 C (bioMerieux).
Susceptibility tests were done with E-tests (AB Biodisck) for Am-
photericin B, Fluconazole, Itraconazole and Voriconazole.
Results: In total number of 1697 microbiological examination, 73
samples (4.3%) were positive. We cultured 88 of fungal strains. 86
(97.7%) of them were yeast like fungi and 2 were moulds (2.3%).
Yeast like fungi isolated from clinical materials belonged to ten
species: C. albicans 41 (47.6%), C. glabrata 16 (18.6%), C. tropicalis
11 (12.8%) and C. parapsilosis 9 (10.5%), other 9 (10.5%). The iso-
lated moulds 2 strains (2.3%) were Aspergillus niger and Aspergillus
fumigatus. We cultured n=31 (35%) fungal strains from respiratory
tract samples and n=14 strains (16%) from blood. The major eti-
ological factors of fungemia in our study were: C. parapsilosis 5
strains, C.albicans 4, C. tropicalis 4. All fungal strains were sen-
sitive to Amphotericin B and Voriconazole, 30% of the C. glabrata
were resistant to Itraconazole. C. albicans strains were sensitive
to Fluconazole. The moulds were sensitive to Amphotericin B and
Voriconazole (100%).
Conclusions: C. albicans species was dominated pathogen cultured
from Department of Medical Intensive Care Unit. C. glabrata was
resistant to Itraconazole in 30%. Amphotericin B and Voriconazole
were the most active in vitro antifungal agents against isolated
fungal strains.
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Risk Factors for Bloodstream Infections due to
Multidrug-resistant Gram-negative Non-fermenting
Bacteria in a Burn Unit
Süheyla Senger1, Funda Timurkaynak1, Hande Arslan1,
Turhan Togan1, Özgür Bas¸aran2, Mehmet Haberal2. 1Department
of Infectious Disease, Baskent University dept of clinical
microbiology and infectious disease Ankara, Turkey; 2General
Surgery, Baskent University dept of clinical microbiology and
infectious disease Ankara, Turkey
Objectives: Gram-negative non-fermenting bacteria are a major
cause of nosocomial infections, and their antibiotic resistance
is an important problem. We evaluated risk factors for blood-
stream infections due to multidrug-resistant, Gram-negative, non-
fermenting bacteria among burn patients.
Methods: This retrospective chart-review study was done at
the burn unit of Baskent University Ankara Hospital in Ankara,
Turkey. Because risk factors for bloodstream infections are due to
multidrug-resistant non-fermenting bacteria, we considered age,
sex, length of hospital stay before a diagnosis of bloodstream in-
fections was made, prior exposure to antibiotics, total burned sur-
face area, ventilatory support, presence of a tracheostomy, and
whether the bloodstream infections was primary or secondary. An-
tibiotic susceptibility testing was done by the Kirby-Bauer method
according to Clinical and Laboratory Standards Institute criteria.
Table 1. Risk factors for multidrug-resistant, Gram-negative,
non-fermenting bacteria and their relation to bloodstream infections
Variable Multidrug-resistant Control P Value
Group Group
(n=10) (n=10)
Mean age (years) 20.9 35.0 0.08
Male sex 9 7 0.26
TBSA* (mean, %) 41.1 46.5 0.71
Length of stay prior to BSI** 28.7 19.0 0.16
Ventilatory support 8 7 0.60
Presence of a tracheostomy 5 4 0.65
Primary BSI 2 7 0.07
Secondary BSI 8 3 0.07
Prior exposure to antibiotics 10 9 0.30
Carbapenems 4 0 0.09
Piperacillin/tazobactam 6 5 0.65
Aminoglycosides 8 0 0.001
Quinolones 3 1 0.26
1st generation cephalosporins 6 3 0.17
3rd generation cephalosporins 9 10 0.30
4th generation cephalosporin 3 1 0.26
Glycopeptides 8 7 0.60
*TBSA: Total body surface area, **BSI: bloodstream infections.
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Multidrug resistance was defined as being intermediate or resistant
to at least 3 of these 6 drugs: amikacin, gentamicin, ciprofloxacin,
piperacillin, ceftazidime, and imipenem.
Results: Forty-eight episodes of bloodstream infections were iden-
tified in 30 patients (5 women; mean age 28.5 years). Gram-
negative isolates were Pseudomonas aeruginosa in 12 (25%), En-
terobacter cloacae in 4 (8.3%), Escherichia coli in 2 (4.2%), and
Acinetobacter spp in 2 (4.2%) of the episodes. There were more
primary bloodstream infections in the control group, whereas sec-
ondary bloodstream infections from wound infections were more
common in patients in the multidrug-resistant group. Regarding
prior antibiotic use, aminoglycoside use was significantly higher in
patients in the multidrug-resistant group (p<0.001). See Table 1.
Conclusion: Multidrug-resistant strains of bacteria are being in-
creasingly reported. In these cases, the choice of therapy often
becomes limited. Several factors suggest that the emergence and
spread of multidrug-resistant non-fermenting bacteria is related to
the overuse of antimicrobial agents, although the degree of risk ap-
pears to differ with different agents. A strong association between
use and resistance has been documented for carbapenems. In this
study, previous use of aminoglycosides was found to be statistically
significant for MDR strains.
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Colistin: An Old Drug for Difficult-to-treat Burn Infections
Caused by Pseudomonas Aeruginosa
Ozlem Kurt Azap1, Funda Timurkaynak1, Hande Arslan1,
Özgür Bas¸aran2, Mehmet Haberal2. 1Department of Infectious
Disease Baskent University Faculty of Medicine, Department of
Infectious Disease, Ankara, Turkey; 2General Surgery, Baskent
University Faculty of Medicine, Department of Infectious Disease,
Ankara, Turkey
Introduction: Colistin was re-introduced into clinical practice dur-
ing the last years for the treatment of nosocomial infections caused
by multidrug-resistant Gram-negative bacteria. The aim of this
study is to evaluate the efficacy and side effects of colistin in the
burn infections caused by pan-resistant Pseudomonas aeruginosa
strains.
Materials and Methods: Medical records of seven burn patients
who received colistin were evaluated retrospectively. Underlying
diseases, site of infection, antibacterial susceptibility pattern of
the causative agent, clinical progress, laboratory findings espe-
cially renal function tests, dose of colistin and side effects of col-
istin were the data collected. Deterioration of renal function was
defined as an increase of more than 50% of the baseline to a value
higher than 1.3mg/dL or as a need for renal replacement therapy.
Results: All seven burn patients had burn wounds infected with
pan-resistant P. aeruginosa and two of these also had bacteremia.
Two burn patients died during colistin treatment; one was due to
other causes except infection (extensive burn), and the other had
febrile disease probably associated with P. aeruginosa. Adult pa-
tients who had normal renal function tests received a dose range
of 1-3 million units q8h. Patients received colistin for 4 to 21 days.
Cultures from the infected sites became sterile in the range of 2
days-13 days. Neurotoxicity, nephrotoxicity, skin rash or gastroin-
testinal disturbances was not observed in any of these patients.
Conclusion: Limited data obtained from seven patients show that
intravenous colistin constitutes a relatively safe and effective ther-
apeutic intervention in cases of severe burn infections caused by
multidrug-resistant Gram-negative bacteria.
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Fungal Infections in Burn Patients
Özlem Azap1, Hande Arslan1, Funda Timurkaynak1, Sezen Özkök1,
Özgür Bas¸aran2, Mehmet Haberal2. 1Department of Infectious
Disease, Baskent University, Ankara, Turkey; 2General Surgery,
Baskent University, Ankara, Turkey
Introduction: Fungal infections particularly bloodstream infections
due to Candida spp. cause high morbidity and mortality in health-
care settings. Burn patients are vulnerable to fungal infections be-
cause they generally receive broad spectrum antibacterial therapy
and total parenteral nutrition.
Objective: The objective of this study is to determine the inci-
dence of fungal infections in burn patients.
Materials and Methods: Medical records of 290 burn patients hos-
pitalized between the years 2003 and 2007 at Baskent University
Burn Unit were evaluated retrospectively. Infections were defined
according to the criteria described in Taneja' s article. Two hun-
dred and ninety burn patients were followed during the five-year
period; the ages of the patients were within the range of 2 months
and 90 years and 88 (30%) were female.
Results: Twenty-five fungal infection episodes caused by Candida
spp. were diagnosed in 20 patients during the five-year period.
Fourteen of these episodes were bloodstream infections, six were
urinary tract infections and five were burn wound infections. Nine
of the fourteen (64%) candidemia episodes were due to Candida
albicans and the remaining five (36%) were due to non-albicans
Candida spp.
Conclusion: Management of fungal infections in burn patients
should deserve more attention because of high mortality rates.
Appropriate antifungal therapy is of great importance. One third
of fungal causes of bloodstream infections in this study are non-
albicans Candida strains. The various antifungal susceptibility pro-
files of non-albicans Candida strains mandates the documentation
of antifungal susceptibility results.
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Caspofungin for Prophylaxis of Intraabdominal Candidiasis
in High-Risk Surgical Patients: a Pilot Study
Laurence Senn, Philippe Eggimann, Riadh Ksontini,
Andres Pascual, Jacques Bille, Thierry Calandra, Oscar Marchetti.
Centre Hospitalier Universitaire Vaudois and University of
Lausanne, Switzerland
Background: We have previously shown that 30-40% of surgical
patients with recurrent gastrointestinal perforation/anastomotic
leakage, or acute necrotizing pancreatitis develop intraabdominal
candidiasis (IC) (Lancet 1989, 2:1437). These patients benefit of
fluconazole prophylaxis (Px) (Crit Care Med 1999, 27:1066). A cor-
rected Candida colonization index (CCI) ≥0.4 is a major risk factor
for IC (Ann Surg 1994, 220:751). CSP, a new therapy for IC including
azole-resistant Candida spp., may be used for Px of IC.
Objective: To conduct a non-comparative pilot study on the effi-
cacy and safety of caspofungin (CSP) for Px of IC in high-risk surgi-
cal patients.
Methods: Inclusion criteria: age >18, surgery for recurrent gas-
trointestinal perforations/anastomotic leakage or acute pancreati-
tis. Exclusion criteria: documented IC, fluconazole Px. CSP Px (70
mg, then 50 mg/day) was given until resolution of the surgical con-
dition. Candida colonization was monitored 1x weekly at ≥3 sites
and the CCI calculated. Success was defined by the absence of IC
during CSP Px. Occurrence of CSP-related SAE was recorded.
Results: Nineteen patients were enrolled: 16/3 males/females,
median age 69 (range 40-84). Underlying surgical conditions were:
recurrent gastrointestinal perforation/anastomotic leakage (n),
